 <h1>Jevtana Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>cabazitaxel</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about cabazitaxel. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Jevtana.</p><h2>In Summary</h2><p><b>Common side effects of Jevtana include:</b> neutropenia, diarrhea, nausea, and vomiting. <b>Other side effects include:</b> febrile neutropenia, hypotension, and dehydration.  See below for a comprehensive list of adverse effects.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to cabazitaxel: intravenous solution</i></p><h3>Warning</h3><p class="blackboxWarning-title">Intravenous route (Solution)</p><p>NeutropeniaNeutropenic deaths have been reported. Monitor for neutropenia with frequent blood cell counts. Cabazitaxel is contraindicated in patients with neutrophil counts of less than or equal to 1500 cells/mm(3). Primary prophylaxis with G-CSF is recommended in patients with high-risk clinical features.Severe HypersensitivitySevere hypersensitivity reactions can occur and may include generalized rash/erythema, hypotension and bronchospasm. Severe hypersensitivity reactions require immediate discontinuation of the cabazitaxel infusion and administration of appropriate therapy. Patients should receive premedication. Cabazitaxel is contraindicated in patients who have a history of severe hypersensitivity reactions to cabazitaxel or to drugs formulated with polysorbate 80.</p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, cabazitaxel (the active ingredient contained in Jevtana) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<i>Check with your doctor or nurse immediately</i> if any of the following side effects occur while taking cabazitaxel:</p><p>
<i>More common</i>
</p><ul>
<li>Black, tarry stools</li>
<li>bleeding gums</li>
<li>bloating or swelling of the face, arms, hands, lower legs, or feet</li>
<li>blood in the urine or stools</li>
<li>burning, numbness, tingling, or painful sensations</li>
<li>chest pain</li>
<li>chills</li>
<li>cough</li>
<li>difficult or labored breathing</li>
<li>difficult or painful urination</li>
<li>fever</li>
<li>lower back or side pain</li>
<li>pale skin</li>
<li>pinpoint red spots on the skin</li>
<li>rapid weight gain</li>
<li>sore throat</li>
<li>sores, ulcers, or white spots on the lips or in the mouth</li>
<li>swollen glands</li>
<li>tightness in the chest</li>
<li>unsteadiness or awkwardness</li>
<li>unusual bleeding or bruising</li>
<li>unusual tiredness or weakness</li>
<li>unusual weight gain or loss</li>
<li>weakness in the arms, hands, legs, or feet</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Blurred vision</li>
<li>confusion</li>
<li>decreased urination</li>
<li>dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position</li>
<li>dry mouth</li>
<li>fainting</li>
<li>fast, slow, or irregular heartbeat</li>
<li>lightheadedness</li>
<li>rapid breathing</li>
<li>sunken eyes</li>
<li>sweating</li>
<li>thirst</li>
<li>wrinkled skin</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Blue lips, fingernails, or skin</li>
<li>burning feeling in the chest or stomach</li>
<li>fast breathing</li>
<li>frequent urination</li>
<li>general feeling of discomfort or illness</li>
<li>indigestion</li>
<li>lower abdominal cramping</li>
<li>nausea</li>
<li>severe constipation</li>
<li>stomach pain or upset</li>
<li>tenderness in the stomach area</li>
<li>thickening of bronchial secretions</li>
<li>vomiting</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of cabazitaxel may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Belching</li>
<li>change in taste</li>
<li>constipation</li>
<li>cracked lips</li>
<li>decreased weight</li>
<li>diarrhea</li>
<li>difficulty with swallowing</li>
<li>hair loss</li>
<li>headache</li>
<li>heartburn</li>
<li>indigestion</li>
<li>lack or loss of strength</li>
<li>loss of appetite</li>
<li>stomach discomfort</li>
<li>thinning of the hair</li>
<li>weight loss</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Back pain</li>
<li>difficulty with moving</li>
<li>muscle pain, spasm, or stiffness</li>
<li>pain in the joints</li>
<li>pain, itching, burning, swelling, or a lump under your skin where the needle is placed</li>
</ul><p>
<!-- end intravenous solution --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to cabazitaxel: intravenous solution</i></p><h3>General</h3><p>The most common adverse events were anemia, leukopenia, neutropenia, thrombocytopenia, and diarrhea.<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Very common</b> (10% or more): Anemia (98%), leukopenia (96%), neutropenia (94%), thrombocytopenia (48%)</p>
<p><b>Common</b> (1% to 10%): Febrile neutropenia<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Diarrhea (47%), nausea (34%), vomiting (22%), constipation (20%), abdominal pain (17%), dyspepsia (10%)</p>
<p><b>Common</b> (1% to 10%): Abdominal pain upper, hemorrhoids, gastroesophageal reflux disease, rectal hemorrhage, dry mouth, abdominal distension</p>
<p><b>Frequency not reported</b>: Death related to diarrhea and electrolyte imbalance, GI hemorrhage and perforation, ileus, enterocolitis, neutropenic enterocolitis, colitis</p>
<p><b>Postmarketing reports</b>: Gastritis, intestinal obstruction<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Fatigue (37%), dysgeusia (11%)</p>
<p><b>Common</b> (1% to 10%): Dizziness, peripheral neuropathy, headache, peripheral sensory neuropathy, paresthesia, lethargy, hypoesthesia, tinnitus, vertigo, sciatica</p>
<p><b>Frequency not reported</b>: Peripheral motor neuropathy, fatal cerebral hemorrhage<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Asthenia (20%), pyrexia (12%)</p>
<p><b>Common</b> (1% to 10%): Mucosal inflammation, pain, death due to causes other than disease progression, malaise<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Dyspnea (12%), cough (11%)</p>
<p><b>Common</b> (1% to 10%): Oropharyngeal pain<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Peripheral edema, arrhythmia, hypotension, deep vein thrombosis, hypertension, tachycardia, grade 3 or higher arrhythmias, orthostatic hypotension, hot flush, flushing, atrial fibrillation </p>
<p><b>Uncommon</b> (0.1% to 1%): Cardiac failure, cardiac arrest, fatal ventricular fibrillation<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Uncommon</b> (0.1% to 1%): Grade 3 to 4 increased AST, grade 3 to 4 increased ALT, increased bilirubin</p>
<p><b>Frequency not reported</b>: Fatal renal failure<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Very common</b> (10% or more): Anorexia (16%)</p>
<p><b>Common</b> (1% to 10%): Weight decreased, dehydration, edema, hyperglycemia, hypokalemia<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Very common</b> (10% or more): Hematuria (17%)</p>
<p><b>Common</b> (1% to 10%): Dysuria, pollakiuria, urinary retention, urinary incontinence, ureteric obstruction, pelvic pain<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Common</b> (1% to 10%): AST increased, transaminases increased</p>
<p><b>Uncommon</b> (0.1% to 1%): ALT increased, bilirubin increased<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Common</b> (1% to 10%): Hypersensitivity<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Very common</b> (10% or more): Back pain (16%), arthralgia (10.5%)</p>
<p><b>Common</b> (1% to 10%): Pain in extremity, muscle spasms, myalgia, musculoskeletal chest pain, flank pain, chills<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Common</b> (1% to 10%): Urinary tract infection, influenza, cystitis, upper respiratory tract infection, pneumonia, cellulitis, herpes zoster, septic shock, sepsis, candidiasis</p>
<p><b>Uncommon</b> (0.1% to 1%): Neutropenic sepsis, neutropenic infections</p>
<p><b>Frequency not reported</b>: Fatal infection<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Very common</b> (10% or more): Alopecia (10%)</p>
<p><b>Common</b> (1% to 10%): Dry skin, erythema<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Common</b> (1% to 10%): Conjunctivitis, increased lacrimation<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Anxiety, confusional state<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. Jevtana (cabazitaxel)." sanofi-aventis , Bridgewater, NJ. </p><p id="ref_2">2. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_3">3. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p></div>
<div class="more-resources" id="moreResources">
<h2>More about Jevtana (cabazitaxel)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>Drug class: mitotic inhibitors</li>
<li>FDA Approval History</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Jevtana &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Prostate Cancer</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to cabazitaxel: intravenous solution</i></p><h3>General</h3><p>The most common adverse events were anemia, leukopenia, neutropenia, thrombocytopenia, and diarrhea.<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Very common</b> (10% or more): Anemia (98%), leukopenia (96%), neutropenia (94%), thrombocytopenia (48%)</p><p><b>Common</b> (1% to 10%): Febrile neutropenia<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Diarrhea (47%), nausea (34%), vomiting (22%), constipation (20%), abdominal pain (17%), dyspepsia (10%)</p><p><b>Common</b> (1% to 10%): Abdominal pain upper, hemorrhoids, gastroesophageal reflux disease, rectal hemorrhage, dry mouth, abdominal distension</p><p><b>Frequency not reported</b>: Death related to diarrhea and electrolyte imbalance, GI hemorrhage and perforation, ileus, enterocolitis, neutropenic enterocolitis, colitis</p><p><b>Postmarketing reports</b>: Gastritis, intestinal obstruction<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Fatigue (37%), dysgeusia (11%)</p><p><b>Common</b> (1% to 10%): Dizziness, peripheral neuropathy, headache, peripheral sensory neuropathy, paresthesia, lethargy, hypoesthesia, tinnitus, vertigo, sciatica</p><p><b>Frequency not reported</b>: Peripheral motor neuropathy, fatal cerebral hemorrhage<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Asthenia (20%), pyrexia (12%)</p><p><b>Common</b> (1% to 10%): Mucosal inflammation, pain, death due to causes other than disease progression, malaise<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Dyspnea (12%), cough (11%)</p><p><b>Common</b> (1% to 10%): Oropharyngeal pain<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Peripheral edema, arrhythmia, hypotension, deep vein thrombosis, hypertension, tachycardia, grade 3 or higher arrhythmias, orthostatic hypotension, hot flush, flushing, atrial fibrillation </p><p><b>Uncommon</b> (0.1% to 1%): Cardiac failure, cardiac arrest, fatal ventricular fibrillation<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Uncommon</b> (0.1% to 1%): Grade 3 to 4 increased AST, grade 3 to 4 increased ALT, increased bilirubin</p><p><b>Frequency not reported</b>: Fatal renal failure<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Very common</b> (10% or more): Anorexia (16%)</p><p><b>Common</b> (1% to 10%): Weight decreased, dehydration, edema, hyperglycemia, hypokalemia<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Very common</b> (10% or more): Hematuria (17%)</p><p><b>Common</b> (1% to 10%): Dysuria, pollakiuria, urinary retention, urinary incontinence, ureteric obstruction, pelvic pain<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Common</b> (1% to 10%): AST increased, transaminases increased</p><p><b>Uncommon</b> (0.1% to 1%): ALT increased, bilirubin increased<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Common</b> (1% to 10%): Hypersensitivity<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Very common</b> (10% or more): Back pain (16%), arthralgia (10.5%)</p><p><b>Common</b> (1% to 10%): Pain in extremity, muscle spasms, myalgia, musculoskeletal chest pain, flank pain, chills<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Common</b> (1% to 10%): Urinary tract infection, influenza, cystitis, upper respiratory tract infection, pneumonia, cellulitis, herpes zoster, septic shock, sepsis, candidiasis</p><p><b>Uncommon</b> (0.1% to 1%): Neutropenic sepsis, neutropenic infections</p><p><b>Frequency not reported</b>: Fatal infection<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Very common</b> (10% or more): Alopecia (10%)</p><p><b>Common</b> (1% to 10%): Dry skin, erythema<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Common</b> (1% to 10%): Conjunctivitis, increased lacrimation<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Anxiety, confusional state<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Jevtana (cabazitaxel)." sanofi-aventis , Bridgewater, NJ. </p><p id="ref_2">2. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_3">3. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><h2>More about Jevtana (cabazitaxel)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>Drug class: mitotic inhibitors</li>
<li>FDA Approval History</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Jevtana &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Prostate Cancer</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>